“Cancer is a brutal disease on both the body and mind. Not only do treatments like chemotherapy take a massive toll, but the emotional side effects can be hard to bear. Depression and anxiety are high among people with cancer, including those in remission. But two new studies offer promising relief through an unlikely source: hallucinogenic drugs.” Read the full TIME article by Alexandra Sifferlin here
“Patrick Mettes was overcome with frustration. He was anxious. His bile duct cancer seemed to bring him more anguish than his wife, Lisa Callaghan, ever realized, she said at a news conference Wednesday. In search of solace, Mettes volunteered for a study in which he was given a synthetic version of psilocybin, a compound found in mind-altering “magic mushrooms,” as a potential treatment for his anxiety and depressed mood. Read the full CNN article by
“In findings that could pry open a door closed for nearly half a century, researchers have found that psilocybin — a hallucinogen long used in traditional healing rituals — eases the depression and soothes the anxiety of patients contending with serious illness and the prospect of imminent death. In two separate studies published Thursday, researchers report that trial subjects who received a single moderate-to-large dose of psilocybin got substantial and lasting relief from their profound
A recent article in OUPblog, the online source for news and commentary from the Oxford University Press, covers changing attitudes towards psychedelics. In “Finding a New Perspective on Psychedelics,” editor Matt Turney notes that “The reputation of these compounds is undergoing rehabilitation, but we can’t know how long it will take to shrug off the weight of the mischaracterizations that have been heaped on them for years.” Turney mentions the work of Heffter researchers Anthony
The States of Consciousness Research Team at Johns Hopkins University is conducting a research study on psychedelic experiences that alter beliefs about death and dying. The study is open to anyone who has had such an experience involving the use of a classic psychedelic such as LSD, psilocybin, mescaline, or DMT. To participate in the study, complete the online Psychedelic Death and Dying Survey. The survey is anonymous and takes about 30 minutes to complete.
The Heffter Research Institute is very grateful to acknowledge a generous financial donation from Breaking Convention, the Conference on Psychedelic Consciousness. At the request of Breaking Convention, their donation will be used to support the NYU clinical trial on psilocybin as a treatment for alcohol addiction. Breaking Convention website Breaking Convention Facebook page
The California Institute of Integral Studies is offering a training program for medical professionals with an interest in psychedelic research and therapy. The program, which begins in the Spring of 2016, involves 180 hours of academic training with prominent faculty, many of whom are affiliated with the Heffter Research Institute. Graduates of the program receive the Certificate in Psychedelic-Assisted Psychotherapies and Research. “The Certificate was created to serve a growing need for trained licensed therapist


Posted on November 19, 2015
The New Yorker magazine offers a detailed and insightful examination of Erowid, the online clearing house for information about psychoactive substances. Writer Emily Witt visits the rural California home of Earth and Fire Erowid, the couple behind the hugely successful web site that attracts a broad following of “drug geeks” and medical professionals. “The average age of Erowid’s thirty thousand Twitter followers is twenty-six. The most frequently looked-at profiles are those of LSD, MDMA, and
In “The Psychedelic Dante,” an article in the February 6, 2015 issue of The American Conservative, writer Rod Dreher discovers parallels between the psychedelic experience and Dante’s Divine Comedy. Dreher begins by noting significant results in current psychedelic science with references to Heffter-supported research by Roland Griffiths, Tony Bossis, and Stephen Ross. Dreher emphasizes the similarity between psychedelic experience and the mystical visions described by Dante. The Psychedelic Dante | The American Conservative  
The Wisconsin Public Radio show “Central Time” recently interviewed two members of the psychedelic research team at the University of Wisconsin School of Pharmacy. (See this blog post for more on the UW study.) Central Time host Veronica Rueckert spoke with Paul Hutson, the lead researcher, and Karen Cooper, the head of the training program for psychedelic guides. UW Conducts Study on Benefits of Psychedelic Mushrooms | WI Public Radio